Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
Abstract
Recent network meta-analyses support the use of pharmacotherapy in patients with generalised anxiety disorder (GAD). Compared with placebo, drug treatment can improve symptoms and quality of life, and is more effective in preventing relapse. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are generally considered the first-line agents of choice in GAD, but in some patients, an alternative evidence-based...
Paper Details
Title
Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
Published Date
Aug 21, 2021
Journal
Volume
38
Issue
S2
Pages
52 - 60
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History